NCT07231172 Post-stroke Fatigue and Clinical Parameters
| NCT ID | NCT07231172 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara University |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 107 participants |
| Start Date | 2024-11-21 |
| Primary Completion | 2026-01-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 107 participants in total. It began in 2024-11-21 with a primary completion date of 2026-01-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the frequency of post-stroke fatigue (PSF) in patients experiencing their first-ever stroke and admitted to our clinic. PSF is a common and debilitating condition that significantly impacts patients' recovery and quality of life. The study will also explore the association between fatigue severity and various demographic and clinical factors such as age, gender, stroke type and duration, pain, mood disorders, sleep quality, motor and cognitive functions, spasticity, physical capacity, ambulation, independence in daily living activities, and health-related quality of life. Patients over 18 years old, at least three months post-stroke, and meeting specific inclusion criteria will be recruited. Fatigue will be assessed using validated scales including the Fatigue Severity Scale and Visual Analog Scale-Fatigue. Additional assessments will measure pain, anxiety, depression, sleep disturbances, motor and cognitive status, spasticity, physical endurance, functional mobility, and daily activity independence. The findings are expected to contribute to a better understanding of PSF and help inform more effective rehabilitation strategies.
Eligibility Criteria
Inclusion Criteria: * Being diagnosed with stroke according to definition by the World Health Organization * Being over 18 years of age * Having had a stroke confirmed by Computed Tomography (CT) and/or Magnetic Resonance Imaging (MRI) * At least 3 months after stroke * At least stage 2 according to the Functional Ambulation Classification * Agreed to participate in the study and signed the informed consent form Exclusion Criteria: * Previous history of stroke * Communication problems due to reasons such as aphasia and dementia * Patients who are illiterate * Cognitive functional impairment who cannot take commands (MMSE\<24) * Dİagnoses such as cancer, heart failure, liver failure, renal failure that may cause fatigue * Signs of systemic infection * History of subarachnoid hemorrhage
Contact & Investigator
Ayşe A. Küçükdeveci, Prof
PRINCIPAL INVESTIGATOR
Ankara University
Frequently Asked Questions
Who can join the NCT07231172 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07231172 currently recruiting?
Yes, NCT07231172 is actively recruiting participants. Contact the research team at yusuf1tekes@gmail.com for enrollment information.
Where is the NCT07231172 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07231172 clinical trial?
NCT07231172 is sponsored by Ankara University. The principal investigator is Ayşe A. Küçükdeveci, Prof at Ankara University. The trial plans to enroll 107 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.